About Raspa
Raspa is a Healthcare company based in Lucknow (India) founded in 2002 by Padmakshi Agarwal and Ram Agarwal. It develops affordable cancer treatments via technological advancements and optimization. It operates on a B2B model. The company has 1 employees. Its chief executive, as recorded, is Padmakshi Agarwal. Raspa offers products and services including Pipeline, Conventional API, and R&D. Its focus areas include Pharmaceuticals, Drug Development, Cancer Treatments and Biotech. Its legal entity in India is Raspa Pharma Pvt Ltd (U24297UP2020PTC132251). Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Raspa Pharma aims to enhance healthcare affordability and accessibility for cancer and severe diseases. The company uses technological innovation and value chain optimization to develop new treatments. It operates in research and development, including pipelines and APIs, while promoting sustainability. Based in Lucknow, India, Raspa targets global healthcare needs through these efforts.
- Headquarters Lucknow, India
- Employees 1
- Founders Padmakshi Agarwal, Ram Agarwal
- SectorsHealthcare
- Website raspapharma.com
- Social LinkedIn X Instagram
- Legal Name Raspa Pharma Pvt Ltd
- Date of Incorporation 05 Aug, 2020
- Jurisdiction Lucknow, Uttar Pradesh, India
- Annual Revenue₹78,208
FY 2024 · +354% YoY
- Net Loss-₹54,138
FY 2024 · -69% margin
- EBITDA-₹54,289
FY 2024 · -69% margin
- Employee Count1
Associated legal entities of Raspa
Raspa operates through Raspa Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Raspa Pharma Private Limited CIN U24297UP2020PTC132251 | Active | 05 Aug 2020 | Lucknow, Uttar Pradesh | ₹0.0 Cr | 3 | View details |
Products & Services of Raspa
Raspa offers a comprehensive portfolio of products and services, including Pipeline, Conventional API, and R&D.
Develops new treatments for cancer and severe diseases.
Produces active ingredients for pharmaceutical applications.
Conducts innovation for affordable healthcare solutions.
Board of directors of Raspa Pharma Private Limited (Raspa)
Raspa Pharma Private Limited is the primary company behind Raspa. The board of Raspa Pharma Private Limited currently have 3 directors; the longest-serving is Sapna Agarwal, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sapna Agarwal DIN 01059975 | Director | 05 Aug 2020 | 6 yrs 2 mo | Raspa Pharma Private Limited |
| Padmakshi Agarwal DIN 08822849 | Director | 05 Aug 2020 | 6 yrs 2 mo | Raspa Pharma Private Limited |
| Ram Agarwal DIN 08822848 | Director | 05 Aug 2020 | 6 yrs 2 mo | Raspa Pharma Private Limited |
People of Raspa
2 people are tracked at Raspa (2 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Raspa
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Raspa
Figures of Raspa Pharma Private Limited, the primary company behind Raspa, for FY 2024. Revenue was ₹78,208 (+354% year on year). Net loss was -₹54,138 (-69% margin). EBITDA was -₹54,289 (-69% margin).
- ₹78,208Revenue · FY 2024 · +354% YoY
- -₹54,138Net loss · -69% margin
- -₹54,289EBITDA · -69% margin
- ₹1.68 CrPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Raspa Pharma Private Limited are on its company page.
Detailed financial statements for Raspa
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Raspa
Raspa has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Raspa
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Raspa
Raspa was founded in 2002.
Raspa is headquartered in Lucknow, India. It is registered at Lucknow, Uttar Pradesh, India.
Padmakshi Agarwal is the CEO of Raspa, as recorded in our data. They have also founded this company.
Raspa has 1 employees.
The primary company behind Raspa, Raspa Pharma Private Limited, reported revenue of ₹78,208 for FY 2024, up 354% year on year.
Raspa Pharma aims to enhance healthcare affordability and accessibility for cancer and severe diseases. The company uses technological innovation and value chain optimization to develop new treatments. It operates in research and development, including pipelines and APIs, while promoting sustainability. Based in Lucknow, India, Raspa targets global healthcare needs through these efforts.
Raspa's top competitors include Laurus Labs, Symbiotec and SeQuent.
Raspa offers Pipeline, Conventional API, and R&D.
Raspa operates through Raspa Pharma Private Limited.
The legal entities of Raspa currently have 3 directors, including Sapna Agarwal, Padmakshi Agarwal, Ram Agarwal.